CADM1 and osteosarcoma: miR-214-3p, targeting the CADM1 3′-UTR, inhibits CADM1 and activates the P44/42 mitogen-activated kinase (MAPK) signaling pathway, thereby promoting the invasion, migration, and proliferation of osteosarcoma.